FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

DEEPAKNTR Consensus Forecast

No. of reports in last year
1
No. of analysts
1
Average Consensus Forecast
938
Consensus Potential
-105.70%

DEEPAKNTR Price Target Potential

BrokerageTargetPotential
CD Equisearch938-105.70%

DEEPAKNTR Targets in FrontPage Forums

10 Users have submitted 11 trade ideas of Rs. 2,327,064.31 for DEEPAKNTR
91% Bullish
9% Bearish
See buy or sell ideas on FrontPage Forums >>

DEEPAKNTR Ratings

Long term DEEPAKNTR rating by FrontPage users
5/5 (2 Ratings)

1 DEEPAKNTR share price target reports by brokerages below. See what is analyst's view on DEEPAKNTR share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
  1. Home
  2. DEEPAKNTR Forum
  3. DEEPAKNTR Price Target

DEEPAKNTR Share Price Target

DEEPAKNTR Share Price Target - Broker Reports - 2020

23-Nov-20
Price @ Call: 819.47
Target: 938
ACCUMULATE
23-Apr-20
Price @ Call: 457.2
Target: 541
BUY
The stock currently trades at 11.1x FY20 EPS of Rs 41.18 and 13.5x FY21e EPS of Rs 33.82. Perilous impact of the virus has shrouded near term business visibility, precipitating some 15% cut in FY21 EPS on lower revenues; Peaking of its performance products margins would doubtlessly take the spin from its current year earnings. Yet partial lifting of trade restrictions and resuscitation of crude oil prices would support a gradual recovery. Commencement of acetone based downstream products sometime in the second quarter of current fiscal would prop up revenues and so would recovery in cracks of phenol and acetone. Balancing odds, we advise accumulating the stock with revised target of Rs 541 (previous target: Rs 396) based on 16x FY21 earnings.
... Read more

DEEPAKNTR Share Price Target - Broker Reports - 2019

27-Nov-19
Price @ Call: 342
Target: 396
BUY
27-Sep-19
Price @ Call: 313.25
Target: 385
BUY
26-Mar-19
Price @ Call: 258.25
Target: 332
BUY
The stock currently trades at 21.7x FY19e EPS of Rs 11.94 and 15.6x FY20e EPS of Rs 16.58. Reduced imports from China coupled with higher dependence on agro chemicals sector, largely explains the recent robustness in performance chemicals business, triggering increased output of both DASDA and OBA. Estimate of some 38.8% growth in earnings next fiscal largely hinges on seamless domestic penetration of phenol & acetone market. Chinese government's expansive crackdown on polluting industries would support domestic off take of agrochemicals, dyes and pigments; though seasonality of agro chemicals business is no small threat. On balance, we maintain our buy rating on the stock with revised target of Rs 332 (previous target: Rs 295) based on 20x FY20e earnings, over a period of 9 months.
... Read more
13-Mar-19
Price @ Call: 264.05
Target: 370
BUY
On a rough cut basis, in FY19, Topline will see a steady rise wherein Topline is expected to touch Rs 2600 crs in FY19E. On the bottomline level we expect the company to record a PAT of Rs 155 crs in FY19E. Thus on a conservative basis, DNL should record a EPS of Rs 11.37 for FY19E. For FY20E and FY21E our expectation is that earnings traction for DNL would continue to be strong wherein we expect a EPS of Rs 18 and Rs 23 respectively.
... Read more

DEEPAKNTR Share Price Target - Broker Reports - 2018

10-Sep-18
Price @ Call: 255.65
Target: 346
BUY
27-Aug-18
Price @ Call: 266.6
Target: 346
BUY
18-Jun-18
Price @ Call: 245.37
Target: 346
BUY
31-May-18
Price @ Call: 245.4
Target: 295
BUY
8-Jan-18
Price @ Call: 273.79
Target: 360
BUY

DEEPAKNTR Share Price Target - Broker Reports - 2017

6-Nov-17
Price @ Call: 222.35
Target: 264
BUY
16-Oct-17
Price @ Call: 217.7
Target: 264
BUY
12-Oct-17
Price @ Call: 215
Target: 251
ACCUMULATE
8-Mar-17
Price @ Call: 122
Target: 144
ACCUMULATE

DEEPAKNTR Share Price Target - Broker Reports - 2016

6-Sep-16
Price @ Call: 125
Target: 153
BUY
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • DEEPAKNTR Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 31,980.35
    Upside Target 21,967.6
    Upside Target 11,950.5
    Pivot1,937.75
    Downside Target 11,920.65
    Downside Target 21,907.9
    Downside Target 31,890.8
  • DEEPAKNTR Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 32,066.3
    Upside Target 22,018.5
    Upside Target 11,975.95
    Pivot1,928.15
    Downside Target 11,885.6
    Downside Target 21,837.8
    Downside Target 31,795.25
  • DEEPAKNTR Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 32,045.28
    Upside Target 21,958.52
    Upside Target 11,883.53
    Pivot1,796.77
    Downside Target 11,721.78
    Downside Target 21,635.02
    Downside Target 31,560.03
  • DEEPAKNTR Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 31,967.6
    Upside Target 21,956.2
    Upside Target 11,949.15
    Pivot1,937.75
    Downside Target 11,926.35
    Downside Target 21,919.3
    Downside Target 31,907.9
  • DEEPAKNTR Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 32,018.5
    Upside Target 21,983.99
    Upside Target 11,962.66
    Pivot1,928.15
    Downside Target 11,893.64
    Downside Target 21,872.31
    Downside Target 31,837.8
  • DEEPAKNTR Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 31,958.52
    Upside Target 21,896.73
    Upside Target 11,858.56
    Pivot1,796.77
    Downside Target 11,734.98
    Downside Target 21,696.81
    Downside Target 31,635.02
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
PrivacyTerms
FrontPage © 2020